The results indicated that ccRCC patients with low expression of FDX1, DLD, DLAT, PDHA1, GLS and PDHB had poor survival probability (HR < 1, P < 0.05), but not CDKN2A (Fig. 3A-G). This evidence concerns the gene GLS and nonpapillary renal cell carcinoma.